JPMorgan Chase & Co. Raises IQVIA (NYSE:IQV) Price Target to $288.00

IQVIA (NYSE:IQV – Free Report) had its target price raised by JPMorgan Chase & Co. from $260.00 to $288.00 in a report released on Monday, Benzinga reports. They currently have an overweight rating on the medical research company’s stock. Several other equities analysts have also commented on IQV. Jefferies Financial Group lowered IQVIA from a […]

Leave a Reply

Your email address will not be published.

Previous post Marchex (NASDAQ:MCHX) Coverage Initiated at StockNews.com
Next post Truist Financial Reiterates Buy Rating for Green Plains (NASDAQ:GPRE)